CLINICAL_TRIALS
trial_result
· 2017-04-07
Clinical Trial Update: Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients [Phase 4]
Summary
Phase 4 trial evaluating the efficacy and tolerability of preservative-free 0.0015% tafluprost in primary open-angle glaucoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gangnam Severance Hospital | Conditions: Primary Open-angle Glaucoma | Phase 4 | Status: COMPLETED